Compare Organon Pharma Indonesia Tbk. (SCPI) vs Surya Pertiwi Tbk. (SPTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Surya Pertiwi Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Surya Pertiwi Tbk. trades at Rp600 (market cap 1.66T, 1.82M 24h volume). The key difference: Surya Pertiwi Tbk. is far larger — about 15.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SPTO | |
|---|---|---|
Market Cap | 104.4B | 1.66T |
Volume | — | 1.82M |
Lot | — | 18.22K |
Turnover | — | 1.1B |
Average Price | — | 603.1 |
Value | — | 1.1B |
Indicative Equilibrium Price | — | 600 |
Indicative Equilibrium Volume | — | 1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Surya Pertiwi Tbk.
PT Surya Pertiwi Tbk (the Company) formerly PT Surya Nusantara was established in the Republic of Indonesia on July 5, 1978 and was published in State Gazette No. 172, Supplement No. 31 dated April 17, 1979 based on Notarial Deed No. 1 of Hendra Karyadi, S.H.
Read more on SPTO →
